Healthcare partnerships—whether among physician-owners, private equity investors, or management groups—often begin with shared vision and enthusiasm. But when one of those partners suddenly wants out, falls ill, retires, or passes away, the absence of a properly drafted buy-sell agreement can create costly disruption. In the healthcare space, where clinics and practices carry not only significant value but also strict regulatory obligations, a vague or boilerplate buy-sell agreement is a risk no organization should ignore.
Why Healthcare Buy-Sell Agreements Are Unique
Unlike generic business ventures, healthcare organizations often require nuanced governance and ownership structures. A surgery center might involve several physicians who also act as managing directors, while a behavioral health clinic may have outside investors with limited voting rights. The differing roles and licensing of owners, combined with state and federal healthcare regulations, mean that buy-sell agreements must go far beyond basic succession planning.
For instance, many states, including Texas and Illinois, impose restrictions on who can own or control a healthcare entity. A buyout provision that transfers equity to an unlicensed or ineligible party could void regulatory compliance or violate anti-kickback statutes. That’s why a legally sound agreement should anticipate these contingencies and build in compliance safeguards.
Triggering Events That Demand Clarity
Common buy-sell triggers—death, disability, retirement, voluntary exit, or termination for cause—require clear definitions and specific procedures. In healthcare settings, a partner’s license revocation or Medicare exclusion could also trigger mandatory divestment. Ambiguity in what counts as a “disability” or “retirement,” or whether the group must approve the successor, often results in litigation.
Take the case of a primary care partnership where one physician sought early retirement. The group had no agreement specifying valuation methods or a process for payout. The resulting dispute over goodwill valuation delayed the transition and cost the clinic both time and money. Avoiding this situation starts with a proactive and legally detailed agreement.
Valuation and Payout Terms Must Be Defensible
The valuation method—whether fixed formula, appraisal-based, or book-value—should reflect the nature of the practice. A dermatology clinic relying heavily on one physician’s patient base may use discounted cash flow, while a multi-site urgent care chain may favor EBITDA multiples.
Whatever the approach, consistency and transparency are key. Courts tend to uphold agreements that follow industry norms and are mutually agreed upon at arm’s length. Disputes often arise when one party claims the valuation was arbitrary or imposed unfairly. Including a mechanism for dispute resolution, such as binding arbitration or third-party appraisers, can further reduce legal exposure.
Funding the Buyout: Life Insurance, Escrows, and Internal Financing
Many buyouts are funded through life insurance, especially in small partnerships where the surviving partners may not have the capital to purchase the deceased partner’s share.
However, the structure of these policies must align with the ownership structure. For example, insurance proceeds may not legally flow directly to investors in a professional corporation.
Escrow arrangements, staged payments, or retention bonuses can help protect both the departing party and the continuing group. Whatever the mechanism, it should be clearly documented in the agreement to avoid future misunderstandings.
Dispute Resolution and Enforcement
Even the best-drafted agreement can be tested in court. That’s why it’s important to include enforceable dispute resolution clauses—arbitration forums, applicable law, jurisdiction, and attorney’s fees—in advance.
One ambulatory surgical center in Texas faced litigation after a buy-sell clause failed to address valuation timing. The agreement was silent on whether earnings post-resignation should be included in the payout. The ambiguity led to arbitration and a protracted enforcement battle. Had the agreement provided clearer exit timelines and calculation cut-offs, the costly dispute may have been avoided.
The Bottom Line for Healthcare Entities
Buy-sell agreements are not just paperwork—they’re governance tools. In healthcare organizations, they also function as compliance documents. Without one, or with a poorly drafted one, clinics risk falling into operational chaos or regulatory violation.
Healthcare legal counsel with industry-specific experience should be consulted when crafting or reviewing these agreements. The goal is not just to protect equity, but to preserve patient care continuity, professional relationships, and operational stability.
If your practice is revisiting succession planning or preparing for growth, ensure your buy-sell agreement is not just legally enforceable—but operationally aligned. A proactive approach today may save your organization from conflict tomorrow.
Is your business protected? Conduct a Legal Audit with us to find your legal vulnerabilities. Visit theoraclelegalgroup.com/legal-audit/
